François‐Xavier Mathy
François‐Xavier Mathy publishes mostly in Cellular and Molecular Neuroscience, Neurology and Pharmaceutical Science, on topics such as Advancements in Transdermal Drug Delivery, Dermatology and Skin Diseases and Drug Transport and Resistance Mechanisms.
- World rank
- #2,214,823 of 7,710,434 ranked researchers
- Rank in Belgium
- #20,266 of 67,186
- Works
- 19
- Citations
- 986
- Citations per work
- 51.9
What does François‐Xavier Mathy research?
François‐Xavier Mathy's work is mostly in Medicine (36%), Neuroscience (12%), Pharmacology, Toxicology and Pharmaceutics (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else842.7%
- Health Sciences736.0%
- Medicine736.0%
- Life Sciences421.3%
- 1Cellular and Molecular Neuroscience12% of their works
- 2Neurology10% of their works
- 3Pharmaceutical Science10% of their works
- 4Pharmacology10% of their works
- 5Dermatology8% of their works
- 6Oncology8% of their works
Research topics
- Advancements in Transdermal Drug Delivery
- Dermatology and Skin Diseases
- Drug Transport and Resistance Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Pharmacological Effects and Toxicity Studies
- Antibiotics Pharmacokinetics and Efficacy
- Neuroscience and Neuropharmacology Research
- Nuclear Receptors and Signaling
Which keywords describe François‐Xavier Mathy's research?
The keywords of their largest research topics: Oxidative Stress, Nuclear Receptors, Dopaminergic Neurons, Parkinson's Disease, ATP-dependent Transporters, Filaggrin, Microneedles and Multidrug Resistance.
- Nurr1
- Synaptic Plasticity
- a-Synuclein
- Genetic Risk Factors
- Antiepileptic Drugs
- Solid Lipid Nanoparticles
- Multidrug Resistance
- Filaggrin
- Parkinson's Disease
- Nuclear Receptors
- Oxidative Stress
- Dopaminergic Neurons
- ATP-dependent Transporters
- Microneedles
- Skin Microbiome
- Antibiotic Pharmacokinetics
- Critically Ill Patients
- Prenatal Exposure
- Neurotransmission
- NR4A2
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Oxidative Stress82 topics
- Nuclear Receptors72 topics
- Dopaminergic Neurons62 topics
- Parkinson's Disease62 topics
- ATP-dependent Transporters51 topic
- Filaggrin51 topic
- Microneedles51 topic
- Multidrug Resistance51 topic
- Skin Microbiome51 topic
- Solid Lipid Nanoparticles51 topic
- Antibiotic Pharmacokinetics41 topic
- Antiepileptic Drugs41 topic
- Critically Ill Patients41 topic
- Genetic Risk Factors41 topic
- Prenatal Exposure41 topic
- a-Synuclein41 topic
- Neurotransmission31 topic
- Synaptic Plasticity31 topic
- NR4A221 topic
- Nurr121 topic
Where does François‐Xavier Mathy work?
François‐Xavier Mathy's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does François‐Xavier Mathy have?
OpenAlex counts 19 works and 986 citations for François‐Xavier Mathy, an h-index of 12, ranking #2,214,823 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about François‐Xavier Mathy. Posts are plain text and can be reported.